ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Efficacy of Familiar Voice Stimulation During Coma Recovery

This study is currently recruiting participants.
Verified by Department of Veterans Affairs, August 2008

Sponsors and Collaborators: Department of Veterans Affairs
Rehabilitation Institute of Chicago
Northwestern Memorial Hospital
Feinberg School of Medicine, Northwestern University
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00557076
  Purpose

The purpose of the study is to determine whether familiar vocal stimulation, provided during coma recovery, improves outcomes for persons who are unconscious after severe TBI. The primary hypothesis is that unconscious persons who receive standard rehabilitation (SR) plus a high-dose of Familiar Voice stimulation (FVs) compared to unconscious persons who receive SR plus a low-dose of FVs (Low Dose Group) and/or unconscious persons receiving SR and sham stimulation (Sham Group) will demonstrate:

  1. Significantly more neurobehavioral functioning post-intervention compared to pre-intervention.
  2. Using Functional Magnetic Resonance Imaging (fMRI), significantly higher average measures of volumetric activity in the whole brain, middle temporal gyrus bilaterally, pri-mary auditory area, bilateral pre-frontal cortex, hippocampus and/or the cerebellum post-intervention compared to pre-intervention.

Condition Intervention Phase
Traumatic Brain Injury
Coma
Vegetative State
Minimally Conscious State
Behavioral: Familiar Voice Stimulation High Dose
Behavioral: Familiar Voice Stimulation Low Dose
Behavioral: Sham Auditory Stimulation
Phase I
Phase II

MedlinePlus related topics:   Head and Brain Injuries    MRI Scans    Rehabilitation   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Dose Comparison, Parallel Assignment, Efficacy Study
Official Title:   Can Neural Adaptation After Severe Brain Injury be Facilitated?

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • DOCS Neurobehavioral Measure (DOCS = DIsorders of Consciousness Scale) [ Time Frame: Immediately after treatment ends ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • FUnctional Magnetic Resonance Imaging (fMRI) [ Time Frame: Immediately after treatment ends ] [ Designated as safety issue: No ]

Estimated Enrollment:   45
Study Start Date:   July 2008
Estimated Study Completion Date:   June 2010
Estimated Primary Completion Date:   March 2010 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
high dose of familiar voice stimulation
Behavioral: Familiar Voice Stimulation High Dose
The High Dose intervention is 1,680 minutes of Familiar Vocal Stimulation (FVs) provided in 40 minute daily segments at least 2 hours apart and for 6 weeks. Four CDs with 10 minutes of FVs preceded by the familiar voice calling out the subject's name, will be played (1 at a time) each day for 6 weeks providing 1,680 minutes of FVs.
2: Active Comparator
low dose of familiar voice stimulaiton
Behavioral: Familiar Voice Stimulation Low Dose
The Low Dose intervention is 210 minutes of Familiar Voice Stimulation is provided in 5 minute daily segments for 6 weeks. One CD with 5 minutes of Familiar Voice Stimulation preceded by the familiar voice calling out the Subject's name then followed by a recording of silence for 5 minutes will be played 1 time each day for 6 weeks. Three other CDs with 10 minutes of silence recorded on each CD will also be played 1 time per day for 6 weeks.
3: Sham Comparator
sham auditory stimulaiton
Behavioral: Sham Auditory Stimulation
The sham intervention is zero minutes of Familiar Voice Stimulation. Each day for 6 weeks 0 minutes of Familiar voice stimulatin will b e provided in 10 minute daily segments for 6 weeks. Each 10 minute recording is a digital recording of silence.

Detailed Description:

Medical advances have improved the odds of surviving a severe traumatic brain injury (TBI) thereby increasing demands for rehabilitation. Medical rehabilitation management during coma recovery, however, has been hampered by a paucity of rigorous clinical trials examining rehabilitation effectiveness. This randomized clinical trial addresses this knowledge gap. The purpose of the study is to determine whether a high dose of familiar vocal stimulation (FVs) improves outcomes for persons who are unconscious after severe TBI. The research objectives are to:

  1. Determine whether neural responses elicited with FVs improve neurobehavioral outcomes and/or elicit activations in expected regions.
  2. Examine the relationship between neurobehavioral and neurophysiological responses to high doses of FVs during coma recovery.

There are three study cohorts and each group receives standard rehabilitation. The experimental group or High-Dose Group will, in addition to standard rehabilitation, be exposed daily to 40 minutes of FVs for 6 weeks. The Low-Dose Group (Control Group 1) will receive standard rehabilitation plus 5 minutes of FVs and 35 minutes of sham treatment daily for 6 weeks. The Sham Group (Control Group 2) will receive standard rehabilitation plus 40 minutes of sham treatment daily for 6 weeks.

The 40 minutes of FVs treatment will be provided in four 10 minutes sessions. Each FV session will start with the subject hearing a familiar voice call the 'Subject's Own Name' aloud and then that same voice re-telling a memory or an event familiar to the subject. The person re-telling the event will be a person who experienced the event with the subject and who interacted with the subject on a daily basis for at least 1 year prior to injury.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Severe brain injury of traumatic origin
  • Non-brain penetrating gun shot wound
  • Blunt trauma with subsequent closed head injuries such as diffuse axonal injury
  • 18 years of age or older
  • Unconscious for at least 28 days consecutively
  • Medically Stable
  • Does not have active seizures

Exclusion Criteria:

  • History of brain injury
  • More than 180 days post injury
  • MRI is contraindicated (e.g., metal, titanium in brain)
  • Ventilator dependent
  • Cardiac contraindications
  • Patient is a recipient of seizure prophylaxis due to active seizures as diagnosed be treating physician
  • The definition of traumatic brain injury excludes: (a) Lacerations or contusions of the face, eye, ear or scalp and fractures of facial bones with-out loss of consciousness; (b) Primary cause of injury is blunt trauma (e.g., contusion from blow to head) without subsequent closed head injuries such as contra coup or diffuse axonal injury; (c) Brain-penetrating gun shot wound; (d) Primary BI due to anoxic, inflammatory, infectious, toxic metabolic encephalopathies; (e) Cancer, brain infarction (ischemic stroke), intracranial hemorrhage (hemorrhagic stroke) aneurysms and arterio-venous malformations.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00557076

Contacts
Contact: Ann Guernon, MS     (630) 909-7146     aguernon@marianjoy.org    

Locations
United States, Illinois
Edward Hines, Jr. VA Hospital     Recruiting
      Hines, Illinois, United States, 60141-3030
      Contact: Ann Guernon, MS     630-909-7146     aguernon@marianjoy.org    
      Principal Investigator: Theresa Louise-Bender Pape, BS MA DrPH            
The Rehabilitation Institute of Chicago     Recruiting
      Chicago, Illinois, United States, 60611
      Contact: Julie Fuith, MS     312-238-1900     jfuith@ric.org    
United States, Virginia
Hunter Holmes McGuire VA Medical Center     Recruiting
      Richmond, Virginia, United States, 23249
      Contact: Shane Mcnamee, MD     804-675-5117     shane.mcnamee@va.gov    

Sponsors and Collaborators
Department of Veterans Affairs
Rehabilitation Institute of Chicago
Northwestern Memorial Hospital
Feinberg School of Medicine, Northwestern University

Investigators
Principal Investigator:     Theresa Louise-Bender Pape, BS MA DrPH     Edward Hines Jr. VA Hospital    
  More Information


Click here for more information about this study: Can Neural Adaptation after Severe Brain Injury be Facilitated?  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Department of Veterans Affairs ( Pape, Theresa - Principal Investigator )
Study ID Numbers:   B4951R
First Received:   November 8, 2007
Last Updated:   August 14, 2008
ClinicalTrials.gov Identifier:   NCT00557076
Health Authority:   United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Randomized Clinical Trial  
Auditory Stimulation  

Study placed in the following topic categories:
Persistent Vegetative State
Craniocerebral Trauma
Unconsciousness
Brain Damage, Chronic
Consciousness Disorders
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases
Trauma, Nervous System
Brain Diseases
Coma
Signs and Symptoms
Neurologic Manifestations
Brain Injuries
Neurobehavioral Manifestations

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on October 10, 2008




Links to all studies - primarily for crawlers